Case Reports: Nephrostomy Tract Tumor Seeding Following Percutaneous Manipulation of a Ureteral Carcinoma

Huang, Andrew H.; Low, Roger K.; White, Ralph deVere

doi:10.1016/s0022-5347(01)67632-8

Cited by 68 publications

(19 citation statements)

References 14 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…There have been multiple reports of TCC seeding after renal mass biopsy, nephrostomy tube placement for obstructive uropathy, and percutaneous management of upper tract TCC. 9,[22][23][24] It is generally considered that these tumours have a higher propensity to implant after percutaneous manipulation than RCC. This risk should be considered when deciding whether to subject a patient to percutaneous renal biopsy.…”

Section: Discussionmentioning

confidence: 99%

Renal cell carcinoma seeding of a percutaneous biopsy tract

Mullins

Rodríguez

2013

CUAJ

View full text Add to dashboard Cite

We report the case of a 68-year-old male with extension of papillary renal cell carcinoma (Fuhrman grade III) along a percutanous biopsy tract detected at the time of partial nephrectomy. Biopsy was performed to a obtain tissue diagnosis of a complex renal cyst as the patient was unable to receive intravenous contrast for imaging due to a severe allergy. Although biopsy of indeterminate renal lesions can provide valuable diagnostic information, there are inherent risks associated with this procedure. The rare occurrence of tumour seeding should be considered when recommending percutaneous biopsy to a patient with a renal mass.

show abstract

Section: Discussionmentioning

confidence: 99%

Renal cell carcinoma seeding of a percutaneous biopsy tract

Mullins

Rodríguez

2013

CUAJ

View full text Add to dashboard Cite

show abstract

“…For example, according to the 2005 American Urological Association clinical guidelines, PCNL is the recommended first-line treatment strategy for calculi with surface area >500 mm 2 (7). Although PCNL can result in a good stone-free rate of 78-95% (8), it has been associated with significant complications, such as loss of a kidney (due to the necessity for complete resection), urinary leakage, uncontrolled hemorrhage, sepsis, tumor seeding, injury to the collecting system and surrounding viscera, or mortality (8,9).…”

Section: Discussionmentioning

confidence: 99%

“…During the treatment of such challenging cases, the possibility of an underlying renal cell carcinoma (RCC) or urothelial carcinoma requires consideration (6,7). Preoperative diagnosis of such lesions may be challenging due to the presence of a stone and the associated inflammatory process.…”

Section: Introductionmentioning

confidence: 99%

Recurrent waist tumor subsequent to percutaneous nephrolithotomy: A case report

et al. 2015

View full text Add to dashboard Cite

Abstract. The present study reports the case of a 39-year old male patient with a recurrent waist tumor that occurred subsequent to percutaneous nephrolithotomy (PCNL). The patient initially underwent PCNL for the management of right calculus of the kidney. Six years later, the patient underwent local mass resection for a tumor at the waist, which was subsequently diagnosed as adenocarcinoma. However, seven months subsequent to local resection, the patient presented to the Affiliated Cancer Hospital of Xiangya Medical School with a one-month history of a recurrent tumor located at the right waist. Physical examination identified no visible skin lesions; however, a palpable hard nodule was present over the right waist. Imaging studies, consisting of computed tomography (CT) and positron emission tomography-CT, indicated no additional metastases. Therefore, the patient underwent local mass resection of the waist tumor. Subsequent histological examination determined a diagnosis of metastatic adenocarcinoma. Considering the previously conducted PCNL surgery and the diagnosis, it is proposed that the recurrent waist tumor originated from renal cell carcinoma (RCC), also termed renal adenocarcinoma. However, no evidence of the original RCC tumor was identified. Therefore, the selection of an effective treatment strategy was challenging.

show abstract

“…The no-touch technique in performing diagnostic ureteroscopy has been previously described [15••]. Percutaneous nephroscopy is another potential diagnostic modality used in patients for whom retrograde access is not possible; however, this approach carries the risk of tumor cells implanting in the retroperitoneum or the nephrostomy tube tract [16].…”

Section: Presentation and Diagnosismentioning

confidence: 99%

Minimally invasive management of upper tract urothelial carcinoma

Joudi¹,

Crane²,

O’Donnell

2006

Curr Urol Rep

View full text Add to dashboard Cite

Recently published studies that evaluated minimally invasive treatments for upper tract urothelial cancer (UTUC) were reviewed, including adjuvant topical therapy. Ureteroscopic management remains the initial diagnostic and possibly therapeutic procedure of choice. Percutaneous management is used to treat bulky tumors or tumors that cannot be accessed ureteroscopically. Low-grade UTUC in appropriately selected patients can be safely and effectively treated endoscopically. High-grade disease tends to fail, regardless of treatment modality, and warrants aggressive therapy. Adjuvant therapy seems to be safe, although its efficacy is debatable. Immunotherapy appears to be most effective in patients with upper tract carcinoma in situ.

show abstract

Case Reports: Nephrostomy Tract Tumor Seeding Following Percutaneous Manipulation of a Ureteral Carcinoma

Cited by 68 publications

References 14 publications

Renal cell carcinoma seeding of a percutaneous biopsy tract

Renal cell carcinoma seeding of a percutaneous biopsy tract

Recurrent waist tumor subsequent to percutaneous nephrolithotomy: A case report

Minimally invasive management of upper tract urothelial carcinoma

Contact Info

Product

Resources

About